Gelteq Limited Ordinary Stock Today
| GELS Stock | 1.86 0.05 2.76% |
Performance0 of 100
| Odds Of DistressLess than 33
|
Gelteq Limited is selling for under 1.86 as of the 29th of November 2024; that is 2.76 percent up since the beginning of the trading day. The stock's lowest day price was 1.86. Gelteq Limited has about a 33 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Gelteq Limited Ordinary are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of October 2024 and ending today, the 29th of November 2024. Click here to learn more.
IPO Date 29th of October 2024 | Category Healthcare |
Gelteq Limited is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 9.44 M outstanding shares of which 1.31 K shares are currently shorted by private and institutional investors with about 0.0 trading days to cover. More on Gelteq Limited Ordinary
Moving against Gelteq Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Gelteq Stock Highlights
| CEO CoFounder | Nathan Givoni | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceutical Products, Drug Manufacturers - Specialty & Generic, Healthcare, Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gelteq Limited can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Gelteq Limited's financial leverage. It provides some insight into what part of Gelteq Limited's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gelteq Limited Ordinary (GELS) is traded on NASDAQ Exchange in USA. It is located in 641 Glen Huntly Road, Caulfield, VIC, Australia, 3162 and employs 7 people. Gelteq Limited is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 17.55 M. Gelteq Limited Ordinary conducts business under Healthcare sector and is part of Drug Manufacturers - Specialty & Generic industry. The entity has 9.44 M outstanding shares of which 1.31 K shares are currently shorted by private and institutional investors with about 0.0 trading days to cover.
Check Gelteq Limited Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Gelteq Limited is USD17.55 Million. Gelteq Limited retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 65.03 (percent) of Gelteq Limited outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Gelteq Ownership Details
Gelteq Limited Historical Income Statement
Gelteq Stock Against Markets
Gelteq Limited Corporate Executives
Elected by the shareholders, the Gelteq Limited's board of directors comprises two types of representatives: Gelteq Limited inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Gelteq. The board's role is to monitor Gelteq Limited's management team and ensure that shareholders' interests are well served. Gelteq Limited's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Gelteq Limited's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Craig Young | CFO Secretary | Profile |
Additional Tools for Gelteq Stock Analysis
When running Gelteq Limited's price analysis, check to measure Gelteq Limited's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gelteq Limited is operating at the current time. Most of Gelteq Limited's value examination focuses on studying past and present price action to predict the probability of Gelteq Limited's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gelteq Limited's price. Additionally, you may evaluate how the addition of Gelteq Limited to your portfolios can decrease your overall portfolio volatility.